title: Chemotherapy-induced cardiomyopathy.
abstract: Improvement in cancer therapy has led to an increasing number of cancer survivors, some of whom may suffer from the cardiotoxic effects of chemotherapy. Cardiomyopathy can occur years after completion of the chemotherapy and it is important to recognize this early, as complete recovery of cardiac function is possible in some cases. In this article we will review chemotherapy-induced cardiomyopathy and discuss its treatment options.
authors.affiliation: University of Texas MD Anderson Cancer Center, Department of Cardiology, 1515 Holcombe Blvd, Unit 1451, Houston, TX 77030, USA. syusuf@mdanderson.org
authors.forename: Syed Wamique
authors.initials: SW
authors.lastname: Yusuf
authors.forename: Nasreen A
authors.initials: NA
authors.lastname: Ilias-Khan
authors.forename: Jean-Bernard
authors.initials: JB
authors.lastname: Durand
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D015415:Biomarkers / Q000097:blood; D009202:Cardiomyopathies / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D016903:Drug Monitoring / Q000379:methods; D042241:Early Diagnosis; D006331:Heart Diseases / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D006333:Heart Failure / Q000139:chemically induced / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D018487:Ventricular Dysfunction, Left / Q000139:chemically induced / Q000150:complications / Q000175:diagnosis / Q000628:therapy
chemical_list: D000970:Antineoplastic Agents; D015415:Biomarkers